DALTON GROUP LIMITED

Financial Health Assessment: DALTON GROUP LIMITED

1. Financial Health Score: B+

Explanation: The patient exhibits a robust underlying constitution characterized by strong overall muscle mass (net assets) and a long history of vitality. However, recent vital signs show acute symptoms of restricted cash flow and a temporary drop in operational efficiency, directly linked to a significant shift in business metabolism (the transition to larger shipment volumes). While the long-term prognosis is positive, the current cash constraints require careful monitoring to avoid liquidity distress.

2. Key Vital Signs

• Net Assets (Muscle Mass): £6,937,034 (2025)
  • Interpretation: Excellent. The company has grown its net assets substantially from £83k in 2014 to nearly £7m in 2025. This indicates a business that has historically built up strong reserves and possesses a solid foundation to weather economic shocks.
• Cash Position (Blood Pressure): £378,240 (2025)
  • Interpretation: Dangerously low relative to recent history. Cash has dropped significantly from £1.78m in 2023 and £942k in 2024. This severe drop suggests the business is experiencing a "cash flow blockage," where capital is trapped in inventory rather than circulating freely as liquid funds.
• Operating Profit (Energy Levels): £418,731 (2025)
  • Interpretation: A sharp decline from £1.8m in 2024. While the director attributes this to the timing of larger shipments (accounting for approximately £720k of the gross margin variance), the drop represents a significant loss of short-term stamina.
• Total Liabilities (Cholesterol): £9,141,849 (2025)
  • Interpretation: Elevated. Liabilities have nearly doubled from £5.03m in 2024 to over £9.1m in 2025. Alongside the massive increase in total assets (jumping from £18.3m to £21.1m), this indicates the company has taken on considerable debt or trade creditors to fund its new high-volume operational model.
• Inventory/Stock (Digestion): £5,792,728 (2025)
  • Interpretation: Heavily bloated. Up from £1.5m in 2024. The company is holding nearly four times as much stock as the previous year, which is the primary cause of the cash drain. The business is effectively "digesting" a much larger meal before it can realize the revenue.

3. Diagnosis

Condition: Acute Cash Flow Strain secondary to Operational Model Transition

The financial data reveals a business in the midst of a major operational transition. Dalton Group Limited has shifted from a higher-frequency, smaller-shipment model to a lower-frequency, bulk-shipment model. This strategic pivot is the root cause of the apparent symptoms of distress.

While the company's "muscle mass" (net assets) remains very healthy, the circulatory system (cash flow) is under severe stress. The patient has essentially swapped highly liquid assets (cash) for illiquid assets (scrap metal inventory) and taken on additional liabilities to fund this stockpiling. The drop in turnover and operating profit is not a symptom of a shrinking market, but rather a timing discrepancy—revenue is only recognized when the massive shipments finally set sail.

The underlying health of the company is fundamentally sound, as confirmed by the auditors' clean bill of health (going concern status). However, the current liquidity position leaves the company highly vulnerable to external shocks. If global scrap metal prices fall suddenly, or if a large shipment is delayed, the company's thin cash reserves could quickly turn into a crisis.

4. Recommendations

To restore full financial wellness and improve this score to an A, the following treatments are prescribed:

1. Liquidity Infusion (Working Capital Management): With cash at critically low levels relative to historical norms, the company must ensure it has adequate working capital facilities in place (such as an overdraft or revolving credit facility) to bridge the gap between purchasing/stockpiling scrap and receiving payment from overseas buyers.
2. Inventory Monitoring (Dietary Control): The massive increase in stock levels requires rigorous management. The company must closely monitor global commodity prices and exchange rates to ensure the value of this bloated inventory does not deteriorate before it is shipped, which would result in a direct hit to equity.
3. Hedging Strategy (Immune System Boost): The strategic report notes exposure to buyers in Turkey and the Far East, creating significant forex risk. The company should implement robust foreign exchange hedging strategies to protect the margins on these large, high-value shipments from sudden currency fluctuations.
4. Dividend Restraint: Given the significant cash drain and reinvestment into inventory, the company was prudent to only pay a modest £168,000 in dividends. Maintaining this restraint until cash flows normalize and stabilize will be crucial for recovery.